Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkers

Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkers

Abstract Introduction There is an urgent need to identify biomarkers that can accurately detect and diagnose Alzheimer's disease (AD). Autoantibodies are abundant and ubiquitous in human sera and have been previously demonstrated as disease‐specific biomarkers capable of accurately diagnosing m...

Full description

Bibliographic Details
Main Authors: Cassandra A. DeMarshall, Eric P. Nagele, Abhirup Sarkar, Nimish K. Acharya, George Godsey, Eric L. Goldwaser, Mary Kosciuk, Umashanger Thayasivam, Min Han, Benjamin Belinka, Robert G. Nagele, Alzheimer's Disease Neuroimaging Initiative
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Mild Cognitive Impairment
Alzheimer's disease
Autoantibodies
Biomarkers
Blood biomarkers
Microarray
Online Access:https://doi.org/10.1016/j.dadm.2016.03.002

Internet

https://doi.org/10.1016/j.dadm.2016.03.002

Similar Items